A new brain-zapping technology may help ease the symptoms of attention deficit hyperactivity disorder (ADHD) in children without some of the side effects stimulant medications can cause, a small, preliminary study suggests. Marked by trouble concentrating, sitting still and/or controlling impulsive behaviors, ADHD affects about 5.3 million children, according to Children and Adults with Attention-Deficit/Hyperactivity…  read on >  read on >

The U.S. Food and Drug Administration on Friday approved a new pill, called zuranolone, that may quickly ease severe postpartum depression and help millions of women regain their emotional equilibrium following childbirth. Taken as a pill once a day for two weeks, zuranolone (Zurzuvae) showed “rapid, significant and sustained” reductions in depressive symptoms when compared…  read on >  read on >

Los Angeles county is seeing more cases of flea-borne typhus, with 171 cases and three deaths reported in 2022, health officials reported Thursday. That’s a big rise, they noted: Since 2010, when only 31 cases of typhus were reported, fleas have been spreading the disease widely in the California city. While many people who become…  read on >  read on >

FRIDAY, Aug. 4, 2023 (HealthDay News) – The U.S. Centers for Disease Control and Prevention on Thursday recommended that all infants under the age of 8 months be given a new antibody shot to help guard against severe respiratory syncytial virus (RSV). The antibody shot, sold as Beyfortus, has been shown to reduce the risk…  read on >  read on >